Skip to content

The effect of Topical heat therapy on Severity of Diabetic Neuropathy and quality of life

The effect of Topical heat therapy on Severity of Diabetic Neuropathy and quality of life in type 2 diabetic patients

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230916059439N1
Enrollment
50
Registered
2024-10-17
Start date
2024-11-05
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic neuropathy. Autonomic neuropathy in diseases classified elsewhere

Interventions

Intervention 1: Patients in the intervention group received heat therapy using hot packs heated to 40 degrees Celsius and at the end of the tibial nerve path in the lower third of the leg and soles of

Sponsors

Gonabad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 65 Years

Inclusion criteria

Inclusion criteria: Having type 2 diabetes (based on the diagnosis of a specialist doctor) with the complication of diabetic neuropathy (based on a minimum score of 2 in the Michigan tool) Patient willingness and written informed consent to participate in the study Age below 65 years Having the power of speech and the ability to communicate to report the severity of clinical symptoms during investigation and examination Not having a history of diseases or conditions that affect neuropathy, such as stroke, multiple sclerosis, gout, Parkinson's, spinal cord injury, Guillain Barre, rheumatic disease, thrombosis and vascular disorder, the presence of cardiac arrhythmias, addiction to drugs or strong painkillers. Based on documentation and self-declaration Not having wounds and lesions in the place of heat therapy Absence of fractures and traumatic injuries leading to sensory and motor lesions in the lower limbs

Exclusion criteria

Exclusion criteria: diseases or conditions that affect neuropathy, such as stroke, multiple sclerosis, gout, Parkinson's, spinal cord injury, Guillain Barre, rheumatic disease, thrombosis and vascular disorder, the presence of cardiac arrhythmias, addiction to drugs or strong painkillers. Based on documentation and self-declaration

Design outcomes

Primary

MeasureTime frame
Severity of Diabetic Neuropathy. Timepoint: Before the intervention and immediately after the intervention. Method of measurement: Michigan Questionnaire.;Quality of life. Timepoint: Before the intervention and immediately after the intervention. Method of measurement: Thomas quality of life questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactReza Ghorbani Noghabi

Gonabad University of Medical Sciences

rezaghorbani8678@gmail.com+98 915 925 9581

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026